Enteric Budesonide Treatment in IgA Nephropathy.

Gulati S, Chaudhary AR, Chauhan S, Saraf K, Khullar D, Jasuja S, Rathore V, Meshram HS, Rovin B

Open source

DOI
10.1016/j.ekir.2026.106412
Published
2026 May
Container
Kidney international reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ekir.2026.106412,
  title = {Enteric Budesonide Treatment in IgA Nephropathy.},
  author = {Gulati S and Chaudhary AR and Chauhan S and Saraf K and Khullar D and Jasuja S and Rathore V and Meshram HS and Rovin B},
  year = {2026},
  journal = {Kidney international reports},
  doi = {10.1016/j.ekir.2026.106412},
  url = {https://doi.org/10.1016/j.ekir.2026.106412}
}

RIS

TY  - JOUR
TI  - Enteric Budesonide Treatment in IgA Nephropathy.
AU  - Gulati S
AU  - Chaudhary AR
AU  - Chauhan S
AU  - Saraf K
AU  - Khullar D
AU  - Jasuja S
AU  - Rathore V
AU  - Meshram HS
AU  - Rovin B
PY  - 2026
JO  - Kidney international reports
DO  - 10.1016/j.ekir.2026.106412
UR  - https://doi.org/10.1016/j.ekir.2026.106412
ER  - 

APA

S, G., AR, C., S, C., K, S., D, K., S, J., V, R., HS, M., & B, R. (2026). Enteric Budesonide Treatment in IgA Nephropathy.. Kidney international reports. https://doi.org/10.1016/j.ekir.2026.106412

Source records